Treatment Continuity Act of 2025
This bill updates federal grant programs to expand access to long-acting injectable medications, lab testing, and counseling for people with substance use disorders or serious mental illness. It requires grant recipients (state/local health agencies) to provide these specific services and train clinicians on medication use. The changes apply to new grants starting after the bill's enactment. Annual reports on program outcomes must also be submitted to Congress.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 17, 2025
Last action Jun 17, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 17, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 17, 2025
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Neal P. Dunn
RRepublican
Co
Aaron Bean
RRepublican
Co
Darren Soto
DDemocratic
Co
Eugene Simon Vindman
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4030
Scope: US
Hi! I can help you understand HR 4030. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline